Custom Content from the Los Angeles Business Journal
Health Care Roundtable
This year, with the COVID-19 crisis and all its accompanying challenges, it has been the health care sector managing and providing treatment – for coronavirus as well as all other health concerns – while providing answers and best practices for the people and businesses of Los Angeles and beyond. As we move into what has become “new normal,” business leaders have many questions. What new protocols are in place? What steps are hospitals taking to protect our safety? Will outpatient care continue to trend upward? How has the insurance coverage landscape altered? To better explore these and many other pressing health-related issues, the Los Angeles Business Journal posed a series of questions to some of the region’s esteemed health industry thought leaders to share their insights.
Inside this supplement:
Study Builds Case for More COVID-19 Antigen Testing
Detecting SARS-CoV-2, the virus that causes COVID-19, improves with regularity of testing, whether using rapid antigen tests or PCR molecular tests. The PCR test is considered the gold standard for diagnosing COVID-19 infection, but cost and infrastructure issues, as well as wait times for PCR results, have limited its use more broadly as a screening tool for asymptomatic people because rapid results are needed to interrupt the chain of transmission…
